Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model

BACKGROUND: To compare the efficacy of low dose (27 mg) Bacillus Calmette-Guérin (BCG) and a full dose (81 mg) BCG immunotherapy for patients with intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) after a typical transurethral bladder resection. METHODS: We constructed a Markov m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zongren, Xiao, Han, Wei, Guangyan, Zhang, Ning, Wei, Mengchao, Chen, Zebin, Peng, Zhenwei, Peng, Sui, Qiu, Shaopeng, Li, Heping, Long, Jianting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233591/
https://www.ncbi.nlm.nih.gov/pubmed/30419836
http://dx.doi.org/10.1186/s12885-018-4988-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233591/
https://www.ncbi.nlm.nih.gov/pubmed/30419836
http://dx.doi.org/10.1186/s12885-018-4988-z

Ejemplares similares